Upon the introduction of the normal RAR ligand, all-trans-retinoic acid, the chimeric receptor undergoes nuclear translocation. 3. Results: Translocation Tracking
The system can detect physiological concentrations of RAR ligands. 4. Discussion and Implications
The GR-RAR chimera is a powerful tool for discovering novel RAR ligands and analogues. It improves upon standard assays that exclusively measure gene activation potential, as this system visualizes the receptor's subcellular trafficking. This technique offers significant advantages in studies exploring ligand-induced receptor dynamics. 5. Conclusion Hem#265 rar
The development of a chimeric receptor that utilizes GR-like translocation properties while retaining RAR ligand specificity provides a robust, visual assay for ligand-receptor interactions. This methodology represents a significant step forward in in vivo monitoring of nuclear receptor signaling. To further refine this paper, please tell me:
The chimeric receptor provides a dramatic and easily monitored visual indicator of RAR ligand presence in the cellular environment. Upon the introduction of the normal RAR ligand,
Nuclear receptors, such as the Retinoic Acid Receptor (RAR), are critical in gene regulation but often difficult to monitor in real-time within living cells. This paper explores the development of a GR-RAR chimeric protein, which fuses the nuclear/cytoplasmic translocation properties of the Glucocorticoid Receptor (GR) with the ligand responsiveness of RAR. This chimeric receptor provides a robust, in vivo, real-time translocation assay to detect physiological concentrations of RAR ligands, providing a powerful tool for ligand identification and subcellular trafficking analysis. 1. Introduction
The translocation from cytoplasm to nucleus is observable in living cells, allowing for kinetic studies. Methodology: Design of the GR-RAR Chimera
This paper highlights a novel method that combines the ligand-binding domain (LBD) of RAR with the trafficking machinery of the GR, creating a chimeric receptor that moves from the cytoplasm to the nucleus upon ligand binding. 2. Methodology: Design of the GR-RAR Chimera